Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura R Prakash

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 25, 2021
GRP78 expression and prognostic significance in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy versus surgery firstYi Tat Tong, Hua Wang, Dongguang Wei, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 22, 2022
Contemporary Assessment of Need for Palliative Bypass After Aborted Pancreatoduodenectomy Following Neoadjuvant TherapyTimothy J Vreeland, Phillip M Kemp Bohan, Timothy E Newhook, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 9, 2021
Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survivalJun Zhao, Luisa M Solis Soto, Hua Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 10, 2022
Radiographic and Serologic Response to First-Line Chemotherapy in Unresected Localized Pancreatic CancerCaitlin A Hester, Giampaolo Perri, Laura R Prakash, et al.
Cancers|June 28, 2023
Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and PancreatoduodenectomyTom Z Liang, Matthew H G Katz, Laura R Prakash, et al.
Pancreas|June 19, 2019
Benefit of Gemcitabine/Nab-Paclitaxel Rescue of Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma After Early Failure of FOLFIRINOXTimothy J Vreeland, Florencia McAllister, Sanaz Javadi, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|July 7, 2022
Comparative analysis of opioid use between robotic and open pancreatoduodenectomyRussell G Witt, Yuki Hirata, Laura R Prakash, et al.
Health Information Management : Journal of the Health Information Management Association of Australia|June 13, 2022
Development and implementation of an institutional enhanced recovery program data processMohamed A Seif, Brittany C Kruse, Cameron A Keramati, et al.
The Journal of Surgical Research|March 20, 2022
Association of Patient Controlled Analgesia and Total Inpatient Opioid Use After PancreatectomyRussell G Witt, Timothy E Newhook, Laura R Prakash, et al.
JAMA Surgery|April 15, 2026
Immunotherapy Response in Microsatellite Instability-High Gastroesophageal AdenocarcinomaJun Okui, Laura R Prakash, Heather G Lyu, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 25, 2021
GRP78 expression and prognostic significance in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy versus surgery firstYi Tat Tong, Hua Wang, Dongguang Wei, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 22, 2022
Contemporary Assessment of Need for Palliative Bypass After Aborted Pancreatoduodenectomy Following Neoadjuvant TherapyTimothy J Vreeland, Phillip M Kemp Bohan, Timothy E Newhook, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 9, 2021
Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survivalJun Zhao, Luisa M Solis Soto, Hua Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 10, 2022
Radiographic and Serologic Response to First-Line Chemotherapy in Unresected Localized Pancreatic CancerCaitlin A Hester, Giampaolo Perri, Laura R Prakash, et al.
Cancers|June 28, 2023
Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and PancreatoduodenectomyTom Z Liang, Matthew H G Katz, Laura R Prakash, et al.
Pancreas|June 19, 2019
Benefit of Gemcitabine/Nab-Paclitaxel Rescue of Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma After Early Failure of FOLFIRINOXTimothy J Vreeland, Florencia McAllister, Sanaz Javadi, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|July 7, 2022
Comparative analysis of opioid use between robotic and open pancreatoduodenectomyRussell G Witt, Yuki Hirata, Laura R Prakash, et al.
Health Information Management : Journal of the Health Information Management Association of Australia|June 13, 2022
Development and implementation of an institutional enhanced recovery program data processMohamed A Seif, Brittany C Kruse, Cameron A Keramati, et al.
The Journal of Surgical Research|March 20, 2022
Association of Patient Controlled Analgesia and Total Inpatient Opioid Use After PancreatectomyRussell G Witt, Timothy E Newhook, Laura R Prakash, et al.
JAMA Surgery|April 15, 2026
Immunotherapy Response in Microsatellite Instability-High Gastroesophageal AdenocarcinomaJun Okui, Laura R Prakash, Heather G Lyu, et al.
Pageof 7